エリスロポエチン変異体
- 专利权人:
- シャリテー ウニベルジテーツメディツィーン-ベルリン
- 发明人:
- マイゼル,アンドレアス,プリラー,ヨゼフ,ボナス,クリステル,ディルナグル,ウルリヒ
- 申请号：
- JP2008510513
- 公开号：
- JP5231214B2
- 申请日:
- 2006.05.15
- 申请国别(地区):
- JP
- 年份:
- 2013
- 代理人:
- 摘要：
- Endogenous new variants of erythropoietin (EPO), as well as treatment or prevention of conditions associated with tissue damage due to inflammation (apoptosis, necrosis) and cell death, neuroprotection particularly, the present invention is, acute disease of the nervous system their use for the treatment of (ALS, for example) chronic disease of the nervous system (eg stroke).本発明は、エリスロポエチン(EPO)の新規な内因性変異体、並びに細胞死(アポトーシス、ネクローシス)及び炎症に起因する組織損傷に関連する症状の治療又は予防、特に神経保護、例えば神経系の急性疾患(例えば卒中)及び神経系の慢性疾患(例えばALS)の治療、のためのその使用に関する。
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Sumoylation control agent and uses thereof
- SYSTEMS AND METHODS FOR DETECTING TISSUE ISCHEMIA AND EVALUATING ORGAN FUNCTION USING SERUM LUMINESCENCE
- BIOORTHOGONAL TWO-COMPONENT DELIVERY SYSTEMS FOR ENHANCED INTERNALIZATION OF NANOTHERAPEUTICS
- Methods and systems for growing plants using silicate-based substrates, cultivating them with enhanced photosynthetic productivity, and photosafeting by using exogenous glycopyranosides against endogenous glycopyranosyl-protein derivatives, And its formulations, processes and systems
- Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same
